
Stefan Aebi, MD, from the Luzerner Kantonsspital, Switzerland, discusses findings from the CALOR trial that examined the administration of adjuvant chemotherapy for women recurrent breast cancer.

Your AI-Trained Oncology Knowledge Connection!


Published: December 6th 2012 | Updated: